Study design
Cancer
DISEASE PROGRESSION, CANCER
The GELATO trial was conducted in accordance with Good Clinical Practice guidelines and the Declaration of Helsinki. All patients provided written informed consent. The trial protocol, informed consent form and amendments were approved by the medical ethical committee of the Netherlands Cancer Institute (NKI). GELATO is a phase II, single-arm, multicenter clinical trial conducted at four centers in the Netherlands (Anti-PD-L1 was continued until disease progression according to RECISTv1.1 (ref. 